Novartis Farmacéutica, S.A. Novartis Pharma GmbH Novartis Poland Sp. z o.o. Salutas Pharma GmbH

The medicine is used to prevent and treat bronchoconstriction in people with bronchial asthma and chronic obstructive pulmonary disease (COPD). It also helps prevent bronchospasms triggered by physical exertion, cold air, or allergens.

Dosage form: powder for inhalation in hard capsules

ATC: R03AC13